You have 9 free searches left this month | for more free features.

NOD-SCID Mice

Showing 1 - 25 of 890

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute-On-Chronic Liver Failure Trial in Beijing (standard medical treatment, hUC-MSC at week0, Placebo at week0)

Not yet recruiting
  • Acute-On-Chronic Liver Failure
  • standard medical treatment
  • +10 more
  • Beijing, Beijing, China
    the Fifth Medical Center, Chinese PLA General Hospital
Aug 15, 2023

Ovarian Cancer Stage IV Trial in France (Pembrolizumab Injectable Product - Chemotherapy - Bevacizumab, Chemotherapy -

Active, not recruiting
  • Ovarian Cancer Stage IV
  • Pembrolizumab Injectable Product - Chemotherapy - Bevacizumab
  • Chemotherapy - Bevacizumab
  • Avignon, France
  • +16 more
Feb 15, 2022

Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and

Recruiting
  • Granuloma
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Hematological Malignancies Trial in Bologna (Intrabone cord blood infusion)

    Completed
    • Hematological Malignancies
    • Intrabone cord blood infusion
    • Bologna, Italy
      Hematology Institute "L. and A. Seràgnoli", S. Orsola-Malpighi U
    Mar 18, 2021

    The Cranio-cervical Flexion Test Using the NOD Device

    Not yet recruiting
    • Muscle Strength
    • +3 more
    • cranio-cervical flexion test with NOD
    • Winterthur, Switzerland
      Zurich University of applied sciences
    Sep 7, 2023

    Severe Combined Immunodeficiency Trial in San Francisco (AProArt, CliniMACS® CD34 Reagent System cell sorter device, Busulfan)

    Recruiting
    • Severe Combined Immunodeficiency
    • San Francisco, California
      University of California, San Francisco (UCSF) Children's Hospit
    Feb 4, 2022

    COVID-19 Respiratory Infection, Influenza Trial in Tucson (COVID-19 Vaccine)

    Recruiting
    • COVID-19 Respiratory Infection
    • Influenza
    • COVID-19 Vaccine
    • Tucson, Arizona
      University of Arizona
    Sep 28, 2021

    Severe Combined Immunodeficiency Disease, X-linked Trial in San Francisco, Memphis, Seattle (genetic, drug, device)

    Recruiting
    • Severe Combined Immunodeficiency Disease, X-linked
    • CL20-i4-EF1α-hγc-OPT
    • +2 more
    • San Francisco, California
    • +2 more
    Jan 9, 2023

    Genetic Basis of Immunodeficiency

    Recruiting
    • Severe Combined Immunodeficiency
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 21, 2023

      Multiple Myeloma Trial in Ann Arbor (Iodine I 131 Tositumomab)

      Active, not recruiting
      • Multiple Myeloma
      • Iodine I 131 Tositumomab
      • Ann Arbor, Michigan
        University of Michigan
      Mar 16, 2022

      Next Generation " Pre-clinical Model for Colorectal Cancer

      Recruiting
      • Colorectal Cancer Metastases and Hepatocellular Carcinomas
      • Tumor /metastases removal
      • Marseille, France
        ap-HM hopital nord
      May 17, 2022

      Severe Combined Immunodeficiency, X-Linked Trial in London (Lentiviral vector transduced CD34+ cells)

      Recruiting
      • Severe Combined Immunodeficiency, X-Linked
      • Lentiviral vector transduced CD34+ cells
      • London, Greater London, United Kingdom
        Great Ormond Street Hospital for Children NHS Foundation Trust
      Mar 15, 2022

      The Experience of Screening for SCID

      Recruiting
      • Severe Combined Immunodeficiency
      • SCID Screening
      • London, United Kingdom
        King's College London
      Dec 6, 2022

      Depressive Disorder Trial in Tanta (Fluoxetine 20 mg, Dapagliflozin 10mg Tab, Atorvastatin 80mg)

      Not yet recruiting
      • Depressive Disorder
      • Fluoxetine 20 mg
      • +2 more
      • Tanta, Shebeen El-Kom, Egypt
        Faculty of Medicine, Menoufia University
      Mar 19, 2023

      Kintsugi Voice Device Study

      Recruiting
      • Depression, Anxiety
      • Kintsugi Voice Device
      • Berkeley, California
        Kintsugi Mindful Wellness, Inc.
      Sep 27, 2022

      Neonatal Screening of Severe Combined Immunodeficiencies

      Completed
      • Severe Combined Immunodeficiency
      • Neonatal Screening
        • Shanghai, Shanghai, China
          Children's Hospital of Fudan University
        Jan 3, 2022

        Artemis (DCLRE1C ) Deficient Severe Combined Immunodeficiency Trial in Paris (ARTEGENE drug product)

        Not yet recruiting
        • Artemis (DCLRE1C ) Deficient Severe Combined Immunodeficiency
        • ARTEGENE drug product
        • Paris, France
          Department of Pediatric Immunology, Hematology and Rheumatology
        Sep 26, 2022

        Memory CD8+ T Cells With Sepsis Severity and

        Recruiting
        • Sepsis
        • Inflammatory Response
          • Wuhan, Hubei, China
            Department of Critical Care Medicine, Union Hospital, Tongji Med
          May 16, 2023

          Type 1 Diabetes Trial in Milan (Sitagliptin, Professional CGM)

          Not yet recruiting
          • Type 1 Diabetes
          • Milan, Italy
            ASST FBF Sacco
          Jun 14, 2022

          Preeclampsia, Labor, Premature Trial in Columbus (Monoket Pill, Placebo)

          Completed
          • Preeclampsia
          • Labor, Premature
          • Monoket Pill
          • Placebo
          • Columbus, Ohio
            The Ohio State Medical Center Labor and Delivery Unit
          Dec 7, 2021

          X-linked Severe Combined Immunodeficiency Trial in Paris (Gene transfer)

          Completed
          • X-linked Severe Combined Immunodeficiency
          • Gene transfer
          • Paris, France
            Hopital Necker
          Sep 22, 2021

          Severe Combined Immunodeficiency Due to RAG1 Deficiency Trial in Leiden (Gene therapy)

          Recruiting
          • Severe Combined Immunodeficiency Due to RAG1 Deficiency
          • Gene therapy
          • Leiden, Netherlands
            Leiden University Medical Center
          Dec 3, 2021

          Physical Inactivity, Phosphate Overload, Visceral Obesity Trial (Sodium Phosphate, Sodium Chloride)

          Not yet recruiting
          • Physical Inactivity
          • +2 more
          • Sodium Phosphate
          • Sodium Chloride
          • (no location specified)
          Aug 5, 2022

          Decoding the Genetic Landscape of Skeletal Diseases

          Recruiting
          • Genetic Skeletal Diseases
          • +3 more
            • Stockholm, Sweden
              Karolinska University Hospital
            May 16, 2023

            Cholesterol Variability, Trained Immunity Trial (Atorvastatin)

            Not yet recruiting
            • Cholesterol Variability
            • Trained Immunity
            • (no location specified)
            Mar 17, 2023